ER 49 articles written Emma Ryan Latest Articles Type 1 & Type 2 Time-in-Range Tips: Expert-Defined Goals, Plus Insights from Almost 500,000 FreeStyle Libre Users new now next Read more Time-in-Range Tips: Expert-Defined Goals, Plus Insights from Almost 500,000 FreeStyle Libre Users Type 1 & Type 2 The Hidden Costs of Discount Cards: Understanding Copay Accumulator Adjustment learning curve Read more The Hidden Costs of Discount Cards: Understanding Copay Accumulator Adjustment Type 2 Type 2 Diabetes Remission: What is it and How Can it be Done? learning curve Read more Type 2 Diabetes Remission: What is it and How Can it be Done? Type 2 A Pill Version of Type 2 Diabetes Therapy Ozempic is Safe for the Heart new now next Read more A Pill Version of Type 2 Diabetes Therapy Ozempic is Safe for the Heart Type 1 & Type 2 BD Discontinues Insulin Pump Infusion Set MiniMed Pro-Set new now next Read more BD Discontinues Insulin Pump Infusion Set MiniMed Pro-Set Type 2 Type 2 Diabetes Therapy Invokana Approved to Reduce Risk of Heart Attack, Stroke, and Heart-Related Death new now next Read more Type 2 Diabetes Therapy Invokana Approved to Reduce Risk of Heart Attack, Stroke, and Heart-Related Death Type 2 Lantus vs. Tresiba: How Do They Compare on Time-in-Range in Type 2 Diabetes? trial watch Read more Lantus vs. Tresiba: How Do They Compare on Time-in-Range in Type 2 Diabetes? Type 1 & Type 2 What’s Next From Tandem? Pump and Closed-Loop Updates from Fall 2018 new now next Read more What’s Next From Tandem? Pump and Closed-Loop Updates from Fall 2018 Type 2 Farxiga Reduces Risk of Heart Failure and Heart-Related Death in Type 2 Diabetes new now next Read more Farxiga Reduces Risk of Heart Failure and Heart-Related Death in Type 2 Diabetes Type 1 & Type 2 EASD Day 1 Highlights – Expert Commentary on Diabetes Therapy and Technology Developments conference pearls Read more EASD Day 1 Highlights – Expert Commentary on Diabetes Therapy and Technology Developments Pages« first ‹ previous 1 2 3 4 5 next › last »
Type 1 & Type 2 Time-in-Range Tips: Expert-Defined Goals, Plus Insights from Almost 500,000 FreeStyle Libre Users new now next Read more Time-in-Range Tips: Expert-Defined Goals, Plus Insights from Almost 500,000 FreeStyle Libre Users
Type 1 & Type 2 The Hidden Costs of Discount Cards: Understanding Copay Accumulator Adjustment learning curve Read more The Hidden Costs of Discount Cards: Understanding Copay Accumulator Adjustment
Type 2 Type 2 Diabetes Remission: What is it and How Can it be Done? learning curve Read more Type 2 Diabetes Remission: What is it and How Can it be Done?
Type 2 A Pill Version of Type 2 Diabetes Therapy Ozempic is Safe for the Heart new now next Read more A Pill Version of Type 2 Diabetes Therapy Ozempic is Safe for the Heart
Type 1 & Type 2 BD Discontinues Insulin Pump Infusion Set MiniMed Pro-Set new now next Read more BD Discontinues Insulin Pump Infusion Set MiniMed Pro-Set
Type 2 Type 2 Diabetes Therapy Invokana Approved to Reduce Risk of Heart Attack, Stroke, and Heart-Related Death new now next Read more Type 2 Diabetes Therapy Invokana Approved to Reduce Risk of Heart Attack, Stroke, and Heart-Related Death
Type 2 Lantus vs. Tresiba: How Do They Compare on Time-in-Range in Type 2 Diabetes? trial watch Read more Lantus vs. Tresiba: How Do They Compare on Time-in-Range in Type 2 Diabetes?
Type 1 & Type 2 What’s Next From Tandem? Pump and Closed-Loop Updates from Fall 2018 new now next Read more What’s Next From Tandem? Pump and Closed-Loop Updates from Fall 2018
Type 2 Farxiga Reduces Risk of Heart Failure and Heart-Related Death in Type 2 Diabetes new now next Read more Farxiga Reduces Risk of Heart Failure and Heart-Related Death in Type 2 Diabetes
Type 1 & Type 2 EASD Day 1 Highlights – Expert Commentary on Diabetes Therapy and Technology Developments conference pearls Read more EASD Day 1 Highlights – Expert Commentary on Diabetes Therapy and Technology Developments
